Comparison of oral betahistine with intravenous diazpam in acute peripheral vertigo
Phase 2
- Conditions
- Acute peripheral vertigo.Diseases of the ear and mastoid process
- Registration Number
- IRCT201112208104N2
- Lead Sponsor
- Tehran university of medical sciences; Deputy of research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patiets over 18 yeras old with peripheral acute vertigo
Exclusion criteria:
contraindications of diazepam and betahistine;
advanced cardiac, pulmonary and cerebrovascular diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom control. Timepoint: 0,2,4 and 6 hours after treatment. Method of measurement: Vertigo severity chart.
- Secondary Outcome Measures
Name Time Method Occurance of drug side effects. Timepoint: during the first 6 hours. Method of measurement: Monitoring the patient.